Alkermes plc. (ALKS) insider trading

Insider

Date

Role

Action

Shares

Price

Amount

David Joseph Gaffin

3 Nov 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,035

$46.17

$93.96K

David Joseph Gaffin

2 Oct 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$41.03

$83.46K

David Joseph Gaffin

3 Sep 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$48.01

$97.65K

Christian Todd Nichols

17 Aug 2026

SVP, Chief Commercial Officer

Sold on a plan

664

$49.65

$32.97K

Christian Todd Nichols

17 Aug 2026

SVP, Chief Commercial Officer

Sold on a plan

6,912

$49.19

$339.97K

David Joseph Gaffin

3 Aug 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$48.58

$98.81K

David Joseph Gaffin

6 Jul 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$54.03

$109.90K

Christopher I Wright

12 Jun 2026

Director

Sold on a plan

2,000

$45.10

$90.20K

David Joseph Gaffin

4 Jun 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$43.05

$87.56K

David Joseph Gaffin

4 May 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$33.20

$67.53K

David Joseph Gaffin

6 Apr 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$34.57

$70.32K

David Joseph Gaffin

3 Mar 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$29.76

$60.53K

David Joseph Gaffin

2 Mar 2026

EVP, CLO, Alkermes, Inc.

Sold on a plan

2,034

$29.29

$59.58K

Christian Todd Nichols

2 Mar 2026

SVP, Chief Commercial Officer

Sold on a plan

6,000

$30.00

$180.00K

Samuel Joseph Parisi

2 Mar 2026

VP, Finance (Interim PAO)

Sold on a plan

6,890

$29.29

$201.81K

Craig C. Hopkinson

2 Jan 2026

EVP R&D, Chief Medical Officer

Sold on a plan

4,000

$28.00

$112.00K

Craig C. Hopkinson

1 Dec 2025

EVP R&D, Chief Medical Officer

Sold on a plan

4,000

$29.30

$117.20K

Alkermes plc.

What the insiders did Scheduled selling only

Individual transactions

What was left out